window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Opinion & Events

  • Biotech & Pharma Business,Opinion & Events

    Bio-Europe unveils renewed vision as global biopharma strategy forum

    Bio-Europe is repositioning its annual conference to expand beyond its [...]

    June 18, 2026
  • Advanced Therapies,Opinion & Events

    AMM and SRT partner to expand ASCENT 2026 RNA therapeutics programme

    The Alliance for mRNA Medicines (AMM) and the Society for [...]

    June 18, 2026
  • Biotech & Pharma Business,Opinion & Events,Therapeutic Areas

    Chiesi launches second Find For Rare research grants programme at ERA 2026

    Chiesi Global Rare Diseases has launched the second edition of [...]

    June 9, 2026
  • Drug Discovery & Development,Opinion & Events,Pharmaceuticals and therapeutics

    Society for RNA Therapeutics expands leadership team

    The Society for RNA Therapeutics (SRT) has expanded its leadership [...]

    June 8, 2026
  • Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    World Bronchiectasis Conference returns to Hannover after decade of progress

    The World Bronchiectasis Conference (WBC) will return to Hannover, Germany, [...]

    June 8, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    Abivax to present nine obefazimod studies at DDW as Phase 3 ulcerative colitis data build

    Abivax will present nine scientific abstracts on obefazimod at Digestive [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    Emalex Biosciences has secured a US patent for an orally [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events

    Phesi data highlights 6.7% of global clinical trials affected by Middle East disruption

    New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events

    Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials

    From hospital haematology to leading early stage clinical trials, Margaret [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events,Pharmaceuticals and therapeutics

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Resolution Therapeutics expands regenerative macrophage pipeline with in vivo mRNA programme
    Categories: Advanced Therapies, Drug Discovery & Development, Therapeutic Areas
  • Gesynta reaches halfway point in Phase 2 endometriosis trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Movianto expands Belgian healthcare logistics hub to 25,000 pallet capacity
    Categories: Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top